University of Bristol, Bristol (United Kingdom of Great Britain & Northern Ireland)
Follow
Contributor content
Presentation
The senolytic agent Dasatinib reduces fat accumulation in the heart and bone marrow of type 2 diabetic, obese mice and adipogenesis of human bone marrow pericytes
